Abstract
Synovial sarcomas are high grade spindle cell tumors that are divided into two major histologic subtypes, biphasic and monophasic, according to the respective presence or absence of a well-developed glandular epithelial component. They contain in essentially all cases a t(X;18) representing the fusion of SYT (at 18q11) with either SSX1 or SSX2 (both at Xp11). Neither SYT, nor the SSX proteins contain DNA-binding domains. Instead, they appear to be transcriptional regulators whose actions are mediated primarily through protein-protein interactions, with BRM in the case of SYT, and with Polycomb group repressors in the case of SSX. Ongoing work on the SYT–SSX fusion and synovial sarcoma should yield a variety of data of broader biological interest, in areas such as BRM and Polycomb group function and dysfunction, transcriptional targets of SYT–SSX proteins and their native counterparts, differential gene regulation by SYT–SSX1 and SYT–SSX2, control of glandular morphogenesis, among others.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allander SV, Chen Y, Illei PB, Antonescu CR, Ladanyi M, Meltzer PS . 2001 Proc. Am. Assoc. Cancer Res. 42: 430
Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M . 2000 Diagn. Mol. Pathol. 9: 1–8
Barr FG . 1998 Nat. Genet. 19: 121–124
Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L . 1998 Mol. Cell Biol. 18: 1489–1497
Birdsall S, Osin P, Lu YJ, Fisher C, Shipley J . 1999 Int. J. Cancer 82: 605–608
Bouffler S, Silver A, Cox R . 1993 Bioessays 15: 409–412
Brett D, Whitehouse S, Per A, Shipley J, Cooper C, Goodwin G . 1997 Hum. Mol. Genet. 6: 1559–1564
Castagnino P, Lorenzi MV, Yeh J, Breckenridge D, Sakata H, Munz B, Werner S, Bottaro DP . 2000 Oncogene 19: 640–648
Chand A, Clark J, Cooper CS, Craig IW . 1995 Genomics 30: 545–552
Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC . 1997 Oncogene 14: 1617–1622
Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS . 1994 Nature Genet. 7: 502–508
Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS . 1995 EMBO J. 14: 2333–2340
de Alava E, Kawai A, Healey JH, Fligman I, Meyers P, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PHB, Barr FG, Ladanyi M . 1998 J. Clin. Oncol. 16: 1248–1255
de Bruijn DR, Baats E, Zechner U, De Leeuw B, Balemans M, Olde Weghuis D, Hirning-Folz U, Geurts van Kessel A . 1996 Oncogene 13: 643–648
De Leeuw B, Balemans M, Geurts van Kessel A . 1996 Cytogenet. Cell Genet. 73: 179–183
De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A . 1995 Hum. Mol. Genet. 4: 1097–1099
De Leeuw B, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Stenman G, Kindblom LG, Balemans M, van den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A . 1994 Cancer Genet. Cytogenet. 73: 89–94
dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, Geurts van Kessel A . 2000 Exp. Cell Res. 256: 192–202
dos Santos NR, de Bruijn DR, Guerts van Kessel A . 2001 Genes Chromosom. Cancer 30: 1–14
dos Santos NR, de Bruijn DRH, Balemans M, Janssen B, Gartner F, Lopes JM, De Leeuw B, van Kessel AG . 1997 Hum. Mol. Genet. 6: 1549–1558
Eid JE, Kung AL, Scully R, Livingston DM . 2000 Cell 102: 839–848
Frisch SM . 1997 Bioessays 19: 705–709
Geurts van Kessel AG, dos Santos NR, Simons A, de Bruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Weghuis DO, Suijkerbuijk RF, van den Berg E, Molenaar WM, De Leeuw B . 1997 Cancer Genet. Cytogenet. 95: 67–73
Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, de Saint A, Michels J, Jundt G, Vince DR, Collin F, Trassard M, Le Doussal V, Benhattar J . 2001 Hum. Pathol. 32: 105–112
Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, Chen YT . 1997 Int. J. Cancer 72: 965–971
Hashimoto N, Araki N, Yoshikawa H, Myoui A, Matsumine A, Kaneko M, Sonobe H, Ochi T . 2000 Cancer Lett. 149: 31–36
Hiraga H, Nojima T, Abe S, Sawa H, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K . 1998 Diag. Mol. Pathol. 7: 102–110
Illei PB, Allander SV, Chen Y, Meltzer PS, Antonescu CR, Ladanyi M . 2001 Mod. Pathol. 14: 13A
Inagaki H, Murase T, Otsuka T, Eimoto T . 1999 Am. J. Clin. Pathol. 111: 528–533
Janz M, De Leeuw B, Olde Weghuis D, Werner M, Nolte M, Geurts van Kessel A, Nordheim A, Hipskind RA . 1995 J. Pathol. 175: 391–396
Kas K, Finger E, Grall F, Gu X, Akbarali Y, Boltax J, Weiss A, Oettgen P, Kapeller R, Libermann TA . 2000 J. Biol. Chem. 275: 2986–2998
Kasai T, Shimajiri S, Hashimoto H . 2000 Mol. Pathol. 53: 107–110
Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M . 1998 New Engl. J. Med. 338: 153–160
Kelly KM, Womer RB, Sorensen PHB, Xiong Q-B, Barr FG . 1997 J. Clin. Oncol. 15: 1831–1836
Kuhnen C, Tolnay E, Steinau HU, Voss B, Muller KM . 1998 Virchows Arch. 432: 337–342
Ladanyi M, Bridge JA . 2000 Hum. Pathol. 31: 532–538
Lee SB, Kolquist KA, Nichols K, Engler C, Shyamala M, Ladanyi M, Gerald WL, Haber DA . 1997 Nature Genet. 17: 309–313
Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF . 2000 J. Clin. Oncol. 18: 2087–2094
Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC . 1998 Oncogene 17: 2013–2018
Lin PP, Brody RI, Hamelin A, Bradner JE, Healey JH, Ladanyi M . 1999 Cancer Res. 59: 1428–1432
Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S . 2000 Lab. Invest. 80: 805–813
Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4509–4513
Miller AP, Gustashaw K, Wolff DJ, Rider SH, Monaco AP, Eble B, Schlessinger D, Gorski JL, van Ommen GJ, Weissenbach J, Willard HF . 1995 Hum. Mol. Genet. 4: 731–739
Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H, Minami A, Hiraga H, Nishihara H, Sawa H, NAgashima K. . 2001 Proc. Natl. Acad. Sci. U.S.A. 98: 3843–3848
Nielsen TO, Brown PO, Botstein D, van de Rijn M . 2001 Mod. Pathol. 14: 16A
Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlen M, Larsson O . 1999 Cancer Res. 59: 3180–3184
Oda Y, Sakamoto A, Saito T, Kinukawa N, Iwamoto Y, Tsuneyoshi M . 2000 Hum. Pathol. 31: 185–192
Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA . 1997 Mol. Cell Biol. 17: 4419–4433
Petermann R, Mossier B, Aryee D, Khazak V, Golemis E, Kovar H . 1998 Oncogene 17: 603–610
Renwick PJ, Reeves BR, Dal Cin P, Fletcher CD, Kempski H, Sciot R, Kazmierczak B, Jani K, Sonobe H, Knight JC . 1995 Cytogenet. Cell Genet. 70: 58–63
Shipley J, Crew J, Birdsall S, Gill S, Clark J, Fisher C, Kelsey A, Nojima T, Sonobe H, Cooper C, Gusterson B . 1996 Am. J. Pathol. 148: 559–567
Shipley JM, Clark J, Crew AJ, Birdsall S, Rocques PJ, Gill S, Chelly J, Monaco AP, Abe S, Gusterson BA, Cooper CS . 1994 Oncogene 9: 1447–1453
Skytting B, Nilsson G, Brodin B, Xie YT, Lundeberg J, Uhlen M, Larsson O . 1999 J. Natl. Cancer Inst. 91: 974–975
Sonobe H, Takeuchi T, Liag SB, Taguchi T, Yuri K, Shimizu K, Iwata J, Furihata M, Ohtsuki Y, Testa JR . 1999 Int. J. Cancer 82: 459–464
Soulez M, Saurin AJ, Freemont PS, Knight JC . 1999 Oncogene 18: 2739–2746
Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, Rayner E, Cooper CS, Goodwin G . 1999 Hum. Mol. Genet. 8: 585–591
Tsarfaty I, Rong S, Resau JH, Rulong S, da Silva PP, Vande Woude GF . 1994 Science 263: 98–101
Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M . 1998 Int. J. Cancer 77: 19–23
Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M . 1996 Cancer Res. 56: 4766–4772
van de Rijn M, Barr FG, Collins MH, Xiong Q-B, Fisher C . 1999 Am. J. Clin. Pathol. 112: 43–49
Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV . 1994 Proc. Natl. Acad. Sci. USA 91: 4514–4518
Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W . 1995 J. Cell Biol. 131: 215–226
Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H . 1996 J. Clin. Oncol. 14: 1245–1251
Acknowledgements
ML is supported by grant PO1 CA47179 from the National Institute of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ladanyi, M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20, 5755–5762 (2001). https://doi.org/10.1038/sj.onc.1204601
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204601
Keywords
This article is cited by
-
Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability
Nature Structural & Molecular Biology (2023)
-
SS18-SSX drives CREB activation in synovial sarcoma
Cellular Oncology (2022)
-
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes
Current Oncology Reports (2020)
-
Fluoreszenz-in-situ-Hybridisierung bei der Diagnostik von Weichgewebs- und Knochentumoren
Der Pathologe (2020)
-
Epitheloide, biphasische und Mischtumoren des Weichgewebes
Der Pathologe (2019)